Target intelligence / Profile preview

Hepatitis C virus nonstructural protein 4A (NS4A) (NS4A)

Target
NS4A
Molecular classification
Enzyme cofactor, Viral protein, Other
01

Overview

Hepatitis C virus nonstructural protein 4A (NS4A) is a small, 54-amino-acid viral polypeptide that plays a critical role in the life cycle of the Hepatitis C virus (HCV). NS4A functions primarily as an essential cofactor for the NS3 serine protease, forming the heterodimeric NS3/4A protease complex. This complex is responsible for the proteolytic cleavage of the viral polyprotein at four junctions (NS3/NS4A, NS4A/NS4B, NS4B/NS5A, and NS5A/NS5B), which is required to release functional viral proteins necessary for replication. Additionally, NS4A contains a hydrophobic N-terminal transmembrane domain that anchors the NS3/4A complex to the outer leaflet of the endoplasmic reticulum membrane, localizing the replication machinery. Beyond its role in replication, NS4A is involved in viral assembly, regulation of NS5A phosphorylation, and host immune evasion by assisting in the cleavage of host proteins like MAVS and TRIF to suppress interferon signaling. While most direct-acting antivirals (DAAs) target the NS3/4A complex as a whole (such as glecaprevir, grazoprevir, and voxilaprevir), specific NS4A inhibitors like ACH-806 (GS-9132) have been developed to disrupt the replication complex by binding directly to NS4A. However, clinical development of direct NS4A inhibitors has faced challenges such as nephrotoxicity.

Other names
Nonstructural protein 4ANS4AHCV NS4AHepatitis C virus nonstructural protein 4ANS3 protease cofactor NS4ANon-structural protein 4A
02

Mechanism of action

Inhibition of the NS3/4A protease complex, preventing viral polyprotein processing and replication; or direct binding to NS4A to disrupt the viral replication complex.

03

Biological functions

Viral replicationProteolysisViral polyprotein processingImmune evasionOther
04

Disease associations

InfectionOther
05

Safety considerations

Rapid emergence of drug resistance (resistance-associated substitutions)Nephrotoxicity (associated with direct NS4A inhibitors like ACH-806)Hepatotoxicity and liver injuryDrug-drug interactions (especially with CYP3A inhibitors or OATP inhibitors)
06

Interacting drugs

12 more in the full profile.

07

Biomarkers

HCV RNA levelsResistance-associated substitutions (RASs) in NS3/4AAlanine aminotransferase (ALT) levelsAspartate aminotransferase (AST) levels

Beyond the preview

Go deeper on Hepatitis C virus nonstructural protein 4A (NS4A) (NS4A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis C virus nonstructural protein 4A (NS4A) (NS4A).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call